GPT and cancer: Recent analysis of large cohorts has begun to reveal the prevalence of ALT in human cancers, highlighting the enrichment of ALT in tumors arising from neuroendocrine systems, mesenchymal and neuroectodermal cells including bone, soft tissues, peripheral and central nervous systems (reviewed in [158]).